Cancer Today Highlights Lessons in Survivorship
Every person who hears the words “you have cancer” has a unique story. As part of Cancer Today’s mission...
Every person who hears the words “you have cancer” has a unique story. As part of Cancer Today’s mission...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
In a 1735 letter to the citizens of Philadelphia about the need to tighten the city’s fire safety measures,...
As we say goodbye to summer, enjoy the selection of articles handpicked by the editors of the AACR journals...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Three patients share their experiences about having Lynch syndrome.
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
Guest Post by Peter A. Jones, PhD, DSc Research Director and Chief Scientific Officer Van Andel Research Institute
Racial/ethnic inequities in cancer are well documented. Not only are Black Americans more likely to die of cancer than white Americans, but Black and Hispanic individuals are...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....
Funded in partnership with the American Association for Cancer Research (AACR), our new Transatlantic Fellowships provide high-potential early-career researchers...
The AACR is a proud production supporter of the new documentary CANCER: THE EMPEROR OF ALL MALADIES, airing on...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
Across the surfaces of your mouth, throat, and nasal sinuses, layers of flat cells called squamous cells protect the...
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
For the first time since 2019, the American Association for Cancer Research (AACR) Annual Meeting is set to return...
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved expanding the use of the immunotherapeutic tisagenlecleucel (Kymriah)...
Guest Post by Charles L. Sawyers, MD AACR Project GENIE Steering Committee Chairperson
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Last week, more than 100 patients, survivors, family members, advocates, and researchers came together for a symposium at the...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
According to the White House, this was the first time a group this expansive and diverse met under a...
In a study published Tuesday in the American Association for Cancer Research’s journal Clinical Cancer Research, researchers identified two...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...